Skip to the page

Data / Form D filings / Endogenex, Inc.

Endogenex, Inc.: Form D filings

Endogenex, Inc., a health care company in Plymouth, MN, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on June 24, 2024, reports $69.6 million sold of a $89.6 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
151 CHESHIRE LANE N, SUITE 400, Plymouth, MN, 55441
Phone
(651) 341-3805
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1730881

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 24, 2024New notice$89,555,019$69,561,279$19,993,74011Jun 13, 2024sec.gov
Oct 17, 2023New notice$18,325,000$18,325,0009Oct 11, 2023sec.gov
Feb 24, 2023New notice$13,000,000$9,209,000$3,791,0007Feb 17, 2023sec.gov
Apr 20, 2021New notice$12,000,000$12,000,0007Apr 15, 2021sec.gov
Dec 6, 2018New notice$12,756,355$12,756,3556Nov 30, 2018sec.gov
Feb 14, 2018New notice$1,000,000$140,000$860,0006Jan 31, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gerald BrunkDirector
Stacey PughExecutive Officer, Director
Jeffrey TerrellDirector
Juliet BakkerDirector
James EadieDirector

Other health care companies in Minnesota that filed recently

Every Form D from the week of Jun 24, 2024 · All recent filings in Minnesota · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Endogenex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.